CELLECTAR BIOSCIENCES, INC.
100 Campus Drive
Florham Park, New Jersey 07932
June 11, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joseph McCann
| Re: | Cellectar Biosciences, Inc. | |
Registration Statement on Form S-1 Filed May 31, 2019 | ||
| File No. 333-231888 |
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-231888), as amended, be accelerated so that the Registration Statement will become effective at 5:00 p.m. on June 11, 2019, or as soon as practicable thereafter.
The cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Gregory J. Lynch (608-283-2240 or gjlynch@michaelbest.com) or Joshua B. Erekson (801-833-0505 or jberekson@michaelbest.com). Thank you for your assistance with these matters.
Very truly yours, | |||
| CELLECTAR BIOSCIENCES, INC. | |||
| By: | /s/ James V. Caruso | ||
| James V. Caruso, President and Chief Executive Officer | |||
| cc: | Charles T. Bernhardt Gregory J. Lynch Joshua B. Erekson |
